Results 281 to 290 of about 169,719 (379)

LCN2‐ACOD1 Signalling Affects the Post‐Injury Regeneration of Skeletal Muscle Through Mediating Ferroptosis

open access: yesCell Proliferation, EarlyView.
LCN2 mediates the suppression of C2C12 myoblast proliferation and myotube formation via erastin‐induced ferroptosis. Mechanistically, the LCN2‐ACOD1 axis regulates skeletal muscle growth via mitochondria‐associated ferroptosis, providing a theoretical basis for the prevention and therapy of muscle‐related diseases.
Xiaojing Hao   +12 more
wiley   +1 more source

Sarcopenia negatively affects preoperative total functional liver volume in patients undergoing liver resection [PDF]

open access: bronze, 2012
Simon Dello   +8 more
openalex   +1 more source

Association of lipid accumulation product with the prevalence and incidence of sarcopenia: a nationwide study in Chinese. [PDF]

open access: yesNutr Metab (Lond)
He Z   +11 more
europepmc   +1 more source

Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology [PDF]

open access: green, 2012
Markus S. Anker   +4 more
openalex   +1 more source

Circulating Muscle Markers for Sarcopenia in Peritoneal Dialysis. [PDF]

open access: yesInt J Nephrol
Xu L   +5 more
europepmc   +1 more source

Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Semaglutide, a GLP‐1 receptor agonist, has shown efficacy in promoting weight loss. However, limited data exist on its impact on lean mass, muscle function, and metabolic adaptations. The SEMALEAN study aims to evaluate these parameters in patients with obesity treated with Semaglutide (2.4 mg).
Mathieu Alissou   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy